BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30756366)

  • 1. High tumor cell vimentin expression indicates prolonged survival in patients with ovarian malignant tumors.
    Szubert S; Koper K; Dutsch-Wicherek MM; Jozwicki W
    Ginekol Pol; 2019; 90(1):11-19. PubMed ID: 30756366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Platelet-derived Growth factor receptors (PDGFRs) and their correlation with overall survival of patients with ovarian cancer.
    Szubert S; Moszynski R; Szpurek D; Romaniuk B; Sajdak S; Nowicki M; Michalak S
    Ginekol Pol; 2019; 90(5):242-249. PubMed ID: 30977516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogenetic consideration of ovarian sex cord-stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads.
    Park SH; Kim I
    Pathol Res Pract; 1994 May; 190(5):449-56. PubMed ID: 7527534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
    Yi BR; Kim TH; Kim YS; Choi KC
    Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
    Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
    Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
    Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer.
    Sonoda K; Miyamoto S; Kobayashi H; Ogawa S; Okugawa K; Taniguchi S; Wake N
    Int J Gynecol Cancer; 2009 Jul; 19(5):838-43. PubMed ID: 19574770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and action of transforming growth factor alpha in normal ovarian surface epithelium and ovarian cancer.
    Doraiswamy V; Parrott JA; Skinner MK
    Biol Reprod; 2000 Sep; 63(3):789-96. PubMed ID: 10952922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian tumors with functioning stroma: a clinicopathologic study with special reference to serum estrogen level, stromal morphology, and aromatase expression.
    Kato N; Hayasaka T; Takeda J; Osakabe M; Kurachi H
    Int J Gynecol Pathol; 2013 Nov; 32(6):556-61. PubMed ID: 24071871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD117 expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients.
    Huang R; Wu D; Yuan Y; Li X; Holm R; Trope CG; Nesland JM; Suo Z
    PLoS One; 2014; 9(11):e112209. PubMed ID: 25380303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
    Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
    Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unclassified sex cord-stromal tumors of the ovary: a report of eight cases.
    Simpson JL; Michael H; Roth LM
    Arch Pathol Lab Med; 1998 Jan; 122(1):52-5. PubMed ID: 9448017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of TEM7 and nestin expression in women with advanced high grade serous ovarian cancer.
    Czekierdowski A; Stachowicz N; Czekierdowska S; Łoziński T; Gurynowicz G; Kluz T
    Ginekol Pol; 2018; 89(3):135-141. PubMed ID: 29664548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival.
    Corvigno S; Wisman GB; Mezheyeuski A; van der Zee AG; Nijman HW; Åvall-Lundqvist E; Östman A; Dahlstrand H
    Oncotarget; 2016 Apr; 7(14):18573-84. PubMed ID: 26918345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
    Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
    Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival.
    Isola J; Kallioniemi OP; Korte JM; Wahlström T; Aine R; Helle M; Helin H
    J Pathol; 1990 Dec; 162(4):295-301. PubMed ID: 2290114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.